Physician profile
Elainne Sher
NPI 1518678598
$2,154.65
in general payments reported to CMS, 2019-2025
11 companies · $82.96 in 2025
The $82.96 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.15 · 2023: $1,366 · 2024: $668 · 2025: $82.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,117.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,404.76 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $270.42 | 2023 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $130.57 | 2024 | |
| Genzyme Corporation | $118.98 | 2024 | |
| Corium, LLC | $68.18 | 2023 | Azstarys |
| Revance Therapeutics, INC. | $57.17 | 2024 | Daxxify |
| Incyte Corporation | $28.62 | 2023 | Opzelura |
| Glaxosmithkline, LLC. | $24.92 | 2025 | Nucala |
| Leo Pharma INC. | $18.77 | 2022 | |
| Ucb, INC. | $18.38 | 2022 | |
| Phadia US INC. | $13.88 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elainne Sher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.